Rare diseases
Investigational molecules
Locations
Back to Romania95 clinical trials in Floresti, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
RomaniaStudy on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability
RomaniaStudy to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery
RomaniaRomaniaStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
RomaniaStudy of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment
RomaniaStudy of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery
RomaniaStudy of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression
RomaniaTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
RomaniaStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
RomaniaGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
RomaniaEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel immunotherapy combinations and targeted treatments.
Multiple studies investigating innovative treatment strategies for both early-stage and metastatic disease.
Research focusing on hormone receptor-positive and HER2-negative breast cancer, exploring new therapeutic combinations and targeted treatments.
Investigations into treatments for both early-stage and advanced breast cancer with various molecular subtypes.
Clinical trials evaluating immunotherapy combinations for treating squamous cell carcinoma of the head and neck, with focus on recurrent and metastatic disease.
Studies examining innovative treatment approaches for various stages of head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
